Head-to-head · WeighScore
GoodRx vs Vitalex Health
The verdict
GoodRx takes it — 69.6/100 to 59.7/100.
GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | GoodRx | Vitalex Health |
|---|---|---|
| WeighScore | 69.6/100 | 59.7/100 |
| Grade | C | C |
| Scorecard rank | #116 | #337 |
| Semaglutide | Not disclosed | $199/mo (starting dose, compounded) |
| Tirzepatide | $299/mo (brand Zepbound) | $199/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #116 · C
Strengths
- $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
- $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
- Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
- No membership fee — bring your own prescription and present the discount card at the pharmacy counter
- Brand-name FDA-approved medication, not compounded
Where it loses points
- Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
- Self-pay only — does not apply toward insurance benefits or deductibles
- Headline price applies to the lowest Foundayo dose; higher doses may cost more
- No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
- Pricing can change as Lilly's manufacturer coupon program evolves
Graded #337 · C
Strengths
- Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
- Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
- Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
- Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
- Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links
Where it loses points
- Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
- No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
- Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
- Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
- Domain was registered in April 2026 — a brand-new practice with no independent reviews found
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.